Nektar Therapeutics
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $416.2M | $1.02B | $68.0M |
| Jun 2022 | $403.3M | $862.0M | $77.5M |
| Sep 2022 | $368.8M | $781.0M | $105.8M |
| Dec 2022 | $344.0M | $710.6M | $88.2M |
| Mar 2023 | $320.9M | $561.7M | $77.0M |
| Jun 2023 | $297.3M | $494.3M | $50.7M |
| Sep 2023 | $282.9M | $442.2M | $64.9M |
| Dec 2023 | $267.0M | $398.0M | $35.3M |
| Mar 2024 | $269.3M | $396.0M | $48.6M |
| Jun 2024 | $263.6M | $343.3M | $27.9M |
| Sep 2024 | $259.1M | $308.0M | $30.1M |
| Dec 2024 | $243.1M | $303.9M | $44.3M |
| Mar 2025 | $242.5M | $256.2M | $38.9M |
| Jun 2025 | $231.7M | $207.5M | $43.0M |
| Sep 2025 | $216.3M | $301.3M | $41.0M |
| Dec 2025 | $190.6M | $280.4M | $15.1M |
| Mar 2026 | $187.1M | $763.3M | $149.6M |
| Jun 2026 | $192.0M | $1.10B | $39.3M |